Expanding the Boundaries of Major Depressive Disorder in DSM-5: The Removal of the Bereavement Exclusion


Expanding the Boundaries of Major Depressive Disorder

Share and Cite:

Searight, H. (2014). Expanding the Boundaries of Major Depressive Disorder in DSM-5: The Removal of the Bereavement Exclusion. Open Journal of Depression, 3, 9-12. doi: 10.4236/ojd.2014.31004.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. DSM-IV-TR (4th ed., text revision). Washington DC: American Psychiatric Association.
[2] American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders. DSM-5 (5th ed.). Washington DC: American Psychiatric Association.
[3] Archer (1999). The nature of grief: The evolution and psychology of reactions to loss. London: Routledge.
[4] Bui, E., Nadal-Vicens, M., & Simon, N. M. (2012). Pharmacological approaches to the treatment of complicated grief: Rationale and a brief review of the literature. Dialogues in Clinical Neuroscience, 14, 149-157.
[5] Callahan, C. M., & Berrios, G. E. (2005). Reinventing depression: A history of the treatment of depression in primary care 1940-2004. New York: Oxford.
[6] Elliott, C. (2000). Pursued by happiness and beaten senseless: Prozac and the American dream. Hastings Center Report, 30, 7-12. http://dx.doi.org/10.2307/3528306
[7] Fontenot, M. B., Kaplan, J. R., Manuck, S. B., Arango, V., & Mann, J. J. (1995). Long-term effects of chronic social stress on serotonergic indices in the prefrontal cortex of adult cynomolgus macaques. Brain Research, 705, 105-108. http://dx.doi.org/10.1016/0006-8993(95)01146-3
[8] Frances, A. (2013). Saving normal. New York: Harper Collins.
[9] Greenberg, G. (2013). The book of woe: The DSM and the unmaking of psychiatry. New York: Penguin.
[10] Hensley, P. L., Slonimiski, C. K., Uhlenhuth, E. H., & Clayton, P. J. (2009). Escitalopram: An open-label study with bereavement-related depression and grief. Journal of Affective Disorders, 113, 142-149.
[11] Horwitz, A. V., & Wakefield, J. C. (2007). The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York: Oxford.
[12] Kitanaka, J. (2012). Depression in Japan: Psychiatric cures for a society in distress. Princeton, NJ: Princeton University Press.
[13] Klerman, G. L. (1972). Psychotropic hedonism vs. pharmacological Calvinism. Hastings Center Report, 3-4.
[14] Kramer, P. (1993). Listening to Prozac: A psychiatrist explores antidepressant drugs and the remaking of the self. New York: Viking.
[15] Lohr, J. M., Hooke, W., Gist, R., & Tolin, D. F. (2003). Novel and controversial treatments for traumatic-related stress disorders. In S. Lilienfeld, S. Lynn, & J. Lohr (Eds.), Science and pseudoscience in clinical psychology. New York: Guilford.
[16] Reynolds, C. F., Miller, M. D., Pasternak, R. E., et al. (1999). Treatment of bereavement-related major depressive episodes in later life: A controlled study of acute and continuation treatment with nortriptylene and interpersonal psychotherapy. American Journal of Psychiatry, 156, 202-208.
[17] Satel, S. (2013). Why the fuss over the DSM-5? New York Times.
[18] Shear, M. K., Fagiolini, A., Houck, P., et al. (2006). Escitalopram for complicated grief: A pilot study. NCDEU 46th Annual Meeting Abstracts, Boca Raton, FL: National Institute of Mental Health.
[19] Wakefield, J. C. (2011). Should uncomplicated bereavement-related depression be reclassified as a disorder in the DSM-5? The Journal of Nervous and Mental Disease, 199, 203-208.
[20] Wakefield, J. C., Schmitz, M. F., First, M. B., & Horwitz, V. (2007). Extending the bereavement exclusion for major depression to other losses. Archives of General Psychiatry, 64, 433-440.
[21] Zisook, S., Shuchter, S. R., Pedrelli, P., Sable, J., & Deacluc, S.C. (2001). Bupropion sustained release for bereavement: Results of an open trial. Clinical Psychiatry, 62, 227-230.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.